Liquid Biopsy Market Size, Share, and Outlook, H2-2025 Report- By Products and Services (Assay Kits, Instruments, Services), By Circulating Biomarkers (Circulating Tumor Cells, Circulating Tumor DNA (ctDNA), Cell-free DNA (cfDNA), Extracellular Vesicles (
Description
Liquid Biopsy Market Outlook
The global Liquid Biopsy Market Size is valued at $6.5 Billion in 2025 and is forecast to reach $13.7 Billion in 2032 at a CAGR of 11.2%.
The Liquid Biopsy Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Liquid Biopsy Market segments across 22 countries from 2021 to 2032. Key segments covered include By Products and Services (Assay Kits, Instruments, Services), By Circulating Biomarkers (Circulating Tumor Cells, Circulating Tumor DNA (ctDNA), Cell-free DNA (cfDNA), Extracellular Vesicles (EVS), Others), By Application (Cancer Application, Non-cancer Applications), By Technology (Multi-gene Parallel Analysis using NGS, Single-gene Analysis using PCR Microarrays), By Clinical Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring), By End-User (Reference Laboratories, Hospitals and Physician Laboratories, Academic & Research Centers, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Liquid Biopsy Market Insights, 2025
The Liquid Biopsy market is revolutionizing cancer diagnostics and monitoring by offering a minimally invasive alternative to tissue biopsies. This technique enables the detection of circulating tumor DNA, RNA, and cells in blood or other body fluids, allowing earlier diagnosis and real-time treatment monitoring. It holds significant promise for guiding personalized therapy decisions, particularly in precision oncology. Technological advancements are improving sensitivity, specificity, and multiplexing capabilities, expanding the range of detectable biomarkers. Beyond oncology, liquid biopsy applications are emerging in prenatal testing, transplant monitoring, and infectious disease detection. Integration with AI-powered analytics is accelerating data interpretation and clinical decision-making. The approach is gaining traction among clinicians due to its potential to reduce patient discomfort and procedure-related risks. Startups and established diagnostics companies are heavily investing in expanding assay portfolios and regulatory clearances. Reimbursement policies and clinical guideline inclusion will play a pivotal role in adoption rates. The market is positioned at the forefront of next-generation diagnostics, offering a blend of clinical utility and patient convenience.
Five Trends Shaping the Global Liquid Biopsy Market in 2025 and Beyond
The global Liquid Biopsy Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Liquid Biopsy Industry?
The Liquid Biopsy Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Liquid Biopsy Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Liquid Biopsy Market Segment Insights
The Liquid Biopsy Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Products and Services (Assay Kits, Instruments, Services), By Circulating Biomarkers (Circulating Tumor Cells, Circulating Tumor DNA (ctDNA), Cell-free DNA (cfDNA), Extracellular Vesicles (EVS), Others), By Application (Cancer Application, Non-cancer Applications), By Technology (Multi-gene Parallel Analysis using NGS, Single-gene Analysis using PCR Microarrays), By Clinical Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring), By End-User (Reference Laboratories, Hospitals and Physician Laboratories, Academic & Research Centers, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Liquid Biopsy Industry Value Chain
The chapter identifies potential companies and their operations across the global Liquid Biopsy Industry ecosystem. It assists decision-makers in evaluating global Liquid Biopsy Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Liquid Biopsy Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Liquid Biopsy Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Liquid Biopsy Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Liquid Biopsy Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Liquid Biopsy Market.
Europe Liquid Biopsy Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Liquid Biopsy Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Liquid Biopsy Industry competitiveness. The report analyses the key Liquid Biopsy Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Liquid Biopsy Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Liquid Biopsy Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Liquid Biopsy Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Liquid Biopsy Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Liquid Biopsy Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Liquid Biopsy Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Biocept Inc, Bio-Rad Laboratories Inc, Exact Sciences Corp, F. Hoffmann-La Roche Ltd, Guardant Health Inc, Illumina Inc, MDxHealth, Myriad Genetics Inc, QIAGEN N.V., Sysmex Inostics, Thermo Fisher Scientific Inc. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Liquid Biopsy Market Scope
Leading Segments
By Products and Services
Assay Kits
Instruments
Services
By Circulating Biomarkers
Circulating Tumor Cells
Circulating Tumor DNA (ctDNA)
Cell-free DNA (cfDNA)
Extracellular Vesicles (EVS)
Others
By Application
Cancer Application
Non-cancer Applications
By Technology
Multi-gene Parallel Analysis using NGS
Single-gene Analysis using PCR Microarrays
By Clinical Application
Early Cancer Screening
Therapy Selection
Treatment Monitoring
Recurrence Monitoring
By End-User
Reference Laboratories
Hospitals and Physician Laboratories
Academic & Research Centers
Others
Leading Companies
Biocept Inc
Bio-Rad Laboratories Inc
Exact Sciences Corp
F. Hoffmann-La Roche Ltd
Guardant Health Inc
Illumina Inc
MDxHealth
Myriad Genetics Inc
QIAGEN N.V.
Sysmex Inostics
Thermo Fisher Scientific Inc
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report Make informed decisions with 12-year forecasts across 22 countries and multiple market segments. Evaluate regulatory impacts, sustainability trends, and disruptive technologies shaping the chemicals industry. Gain insights into the competitive landscape, including company profiles, financials, and strategic moves. Build an integrated understanding of the chemicals ecosystem across upstream, midstream, and downstream operations. Leverage insights on circular economy initiatives, digitalization, and carbon-neutral strategies driving the next decade. Assess risks and opportunities with scenario-based forecasts tailored to different growth conditions. Access the report in multiple formats (PDF, Excel, PPT) for easier integration into strategic planning.
The global Liquid Biopsy Market Size is valued at $6.5 Billion in 2025 and is forecast to reach $13.7 Billion in 2032 at a CAGR of 11.2%.
The Liquid Biopsy Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Liquid Biopsy Market segments across 22 countries from 2021 to 2032. Key segments covered include By Products and Services (Assay Kits, Instruments, Services), By Circulating Biomarkers (Circulating Tumor Cells, Circulating Tumor DNA (ctDNA), Cell-free DNA (cfDNA), Extracellular Vesicles (EVS), Others), By Application (Cancer Application, Non-cancer Applications), By Technology (Multi-gene Parallel Analysis using NGS, Single-gene Analysis using PCR Microarrays), By Clinical Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring), By End-User (Reference Laboratories, Hospitals and Physician Laboratories, Academic & Research Centers, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Liquid Biopsy Market Insights, 2025
The Liquid Biopsy market is revolutionizing cancer diagnostics and monitoring by offering a minimally invasive alternative to tissue biopsies. This technique enables the detection of circulating tumor DNA, RNA, and cells in blood or other body fluids, allowing earlier diagnosis and real-time treatment monitoring. It holds significant promise for guiding personalized therapy decisions, particularly in precision oncology. Technological advancements are improving sensitivity, specificity, and multiplexing capabilities, expanding the range of detectable biomarkers. Beyond oncology, liquid biopsy applications are emerging in prenatal testing, transplant monitoring, and infectious disease detection. Integration with AI-powered analytics is accelerating data interpretation and clinical decision-making. The approach is gaining traction among clinicians due to its potential to reduce patient discomfort and procedure-related risks. Startups and established diagnostics companies are heavily investing in expanding assay portfolios and regulatory clearances. Reimbursement policies and clinical guideline inclusion will play a pivotal role in adoption rates. The market is positioned at the forefront of next-generation diagnostics, offering a blend of clinical utility and patient convenience.
Five Trends Shaping the Global Liquid Biopsy Market in 2025 and Beyond
The global Liquid Biopsy Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Liquid Biopsy Industry?
The Liquid Biopsy Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Liquid Biopsy Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Liquid Biopsy Market Segment Insights
The Liquid Biopsy Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Products and Services (Assay Kits, Instruments, Services), By Circulating Biomarkers (Circulating Tumor Cells, Circulating Tumor DNA (ctDNA), Cell-free DNA (cfDNA), Extracellular Vesicles (EVS), Others), By Application (Cancer Application, Non-cancer Applications), By Technology (Multi-gene Parallel Analysis using NGS, Single-gene Analysis using PCR Microarrays), By Clinical Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring), By End-User (Reference Laboratories, Hospitals and Physician Laboratories, Academic & Research Centers, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Liquid Biopsy Industry Value Chain
The chapter identifies potential companies and their operations across the global Liquid Biopsy Industry ecosystem. It assists decision-makers in evaluating global Liquid Biopsy Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Liquid Biopsy Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Liquid Biopsy Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Liquid Biopsy Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Liquid Biopsy Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Liquid Biopsy Market.
Europe Liquid Biopsy Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Liquid Biopsy Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Liquid Biopsy Industry competitiveness. The report analyses the key Liquid Biopsy Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Liquid Biopsy Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Liquid Biopsy Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Liquid Biopsy Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Liquid Biopsy Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Liquid Biopsy Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Liquid Biopsy Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Biocept Inc, Bio-Rad Laboratories Inc, Exact Sciences Corp, F. Hoffmann-La Roche Ltd, Guardant Health Inc, Illumina Inc, MDxHealth, Myriad Genetics Inc, QIAGEN N.V., Sysmex Inostics, Thermo Fisher Scientific Inc. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Liquid Biopsy Market Scope
Leading Segments
By Products and Services
Assay Kits
Instruments
Services
By Circulating Biomarkers
Circulating Tumor Cells
Circulating Tumor DNA (ctDNA)
Cell-free DNA (cfDNA)
Extracellular Vesicles (EVS)
Others
By Application
Cancer Application
Non-cancer Applications
By Technology
Multi-gene Parallel Analysis using NGS
Single-gene Analysis using PCR Microarrays
By Clinical Application
Early Cancer Screening
Therapy Selection
Treatment Monitoring
Recurrence Monitoring
By End-User
Reference Laboratories
Hospitals and Physician Laboratories
Academic & Research Centers
Others
Leading Companies
Biocept Inc
Bio-Rad Laboratories Inc
Exact Sciences Corp
F. Hoffmann-La Roche Ltd
Guardant Health Inc
Illumina Inc
MDxHealth
Myriad Genetics Inc
QIAGEN N.V.
Sysmex Inostics
Thermo Fisher Scientific Inc
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report
Table of Contents
198 Pages
- 1. Table of Contents
- List of Figures and Tables
- 2. Executive Summary
- 2.1 Key Highlights
- 2.1.1 Liquid Biopsy Market Size Outlook, 2018-2024 and 2025-2032
- 2.1.2 Largest Liquid Biopsy Market Types and Applications
- 2.1.3 Fastest Growing Segments
- 2.1.4 Potential Markets
- 2.1.5 Market Concentration
- 2.2 Market Scope and Segmentation
- 2.2.1 Market Scope- Segments
- 2.2.2 Market Scope- Countries
- 2.2.3 Macroeconomic and Demographic Outlook
- 2.2.4 Abbreviations
- 2.2.5 Units and Currency Conversions
- 3. Research Methodology
- 3.1 Primary Research Surveys
- 3.2 Secondary Data Sources
- 3.3 Data Triangulation
- 3.4 Forecast Methodology
- 3.5 Assumptions and Limitations
- 4. Introduction to Global Liquid Biopsy Market in 2025
- 4.1 Industry Panorama
- 4.2 Leading Companies Profiled in the Study
- 4.3 Asia Pacific Markets offer Robust Market Prospects for New Entrants
- 4.4 Market Dynamics
- 4.4.1 Market Dynamics- Trends and Drivers
- 4.4.2 Market Dynamics- Opportunities and Challenges
- 4.5 Regional Analysis
- 4.6 Porter’s Five Force Analysis
- 4.6.1 Intensity of Competitive Rivalry
- 4.6.2 Threat of New Entrants
- 4.6.3 Threat of Substitutes
- 4.6.4 Bargaining Power of Buyers
- 4.6.5 Bargaining Power of Suppliers
- 4.7 Liquid Biopsy Market Industry Value Chain Analysis
- 4.7.1 Stage of Value Chain
- 4.7.2 Key Activities of Companies
- 4.7.3 Companies Included in Each Stage
- 4.7.4 Key Insights
- 5. Liquid Biopsy Market Outlook to 2032
- 5.1 Market Size Forecast by Type, 2021-2024 and 2025-2032
- 5.2 Market Size Forecast by Application, 2021-2024 and 2024-2032
- 5.3 Market Size Forecast by Geography, 2021-2024 and 2024-2032
- By Products and Services
- Assay Kits
- Instruments
- Services
- By Circulating Biomarkers
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles (EVS)
- Others
- By Application
- Cancer Application
- Non-cancer Applications
- By Technology
- Multi-gene Parallel Analysis using NGS
- Single-gene Analysis using PCR Microarrays
- By Clinical Application
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- By End-User
- Reference Laboratories
- Hospitals and Physician Laboratories
- Academic & Research Centers
- Others
- 6. Global Liquid Biopsy Market Outlook across Growth Scenarios
- 6.1 Low Growth Scenario
- 6.2 Base/Reference Case
- 6.3 High Growth Scenario
- 6. North America Liquid Biopsy Market Size Outlook
- 6.1 Key Market Statistics, 2024
- 6.2 North America Liquid Biopsy Market Trends and Growth Opportunities
- 6.2.1 North America Liquid Biopsy Market Outlook by Type
- 6.2.2 North America Liquid Biopsy Market Outlook by Application
- 6.3 North America Liquid Biopsy Market Outlook by Country
- 6.3.1 The US Liquid Biopsy Market Outlook, 2021- 2032
- 6.3.2 Canada Liquid Biopsy Market Outlook, 2021- 2032
- 6.3.3 Mexico Liquid Biopsy Market Outlook, 2021- 2032
- 7. Europe Liquid Biopsy Market Size Outlook
- 7.1 Key Market Statistics, 2024
- 7.2 Europe Liquid Biopsy Market Trends and Growth Opportunities
- 7.2.1 Europe Liquid Biopsy Market Outlook by Type
- 7.2.2 Europe Liquid Biopsy Market Outlook by Application
- 7.3 Europe Liquid Biopsy Market Outlook by Country
- 7.3.2 Germany Liquid Biopsy Market Outlook, 2021- 2032
- 7.3.3 France Liquid Biopsy Market Outlook, 2021- 2032
- 7.3.4 The UK Liquid Biopsy Market Outlook, 2021- 2032
- 7.3.5 Spain Liquid Biopsy Market Outlook, 2021- 2032
- 7.3.6 Italy Liquid Biopsy Market Outlook, 2021- 2032
- 7.3.7 Russia Liquid Biopsy Market Outlook, 2021- 2032
- 7.3.8 Rest of Europe Liquid Biopsy Market Outlook, 2021- 2032
- 8. Asia Pacific Liquid Biopsy Market Size Outlook
- 8.1 Key Market Statistics, 2024
- 8.2 Asia Pacific Liquid Biopsy Market Trends and Growth Opportunities
- 8.2.1 Asia Pacific Liquid Biopsy Market Outlook by Type
- 8.2.2 Asia Pacific Liquid Biopsy Market Outlook by Application
- 8.3 Asia Pacific Liquid Biopsy Market Outlook by Country
- 8.3.1 China Liquid Biopsy Market Outlook, 2021- 2032
- 8.3.2 India Liquid Biopsy Market Outlook, 2021- 2032
- 8.3.3 Japan Liquid Biopsy Market Outlook, 2021- 2032
- 8.3.4 South Korea Liquid Biopsy Market Outlook, 2021- 2032
- 8.3.5 Australia Liquid Biopsy Market Outlook, 2021- 2032
- 8.3.6 South East Asia Liquid Biopsy Market Outlook, 2021- 2032
- 8.3.7 Rest of Asia Pacific Liquid Biopsy Market Outlook, 2021- 2032
- 9. South America Liquid Biopsy Market Size Outlook
- 9.1 Key Market Statistics, 2024
- 9.2 South America Liquid Biopsy Market Trends and Growth Opportunities
- 9.2.1 South America Liquid Biopsy Market Outlook by Type
- 9.2.2 South America Liquid Biopsy Market Outlook by Application
- 9.3 South America Liquid Biopsy Market Outlook by Country
- 9.3.1 Brazil Liquid Biopsy Market Outlook, 2021- 2032
- 9.3.2 Argentina Liquid Biopsy Market Outlook, 2021- 2032
- 9.3.3 Rest of South and Central America Liquid Biopsy Market Outlook, 2021- 2032
- 10. Middle East and Africa Liquid Biopsy Market Size Outlook
- 10.1 Key Market Statistics, 2024
- 10.2 Middle East and Africa Liquid Biopsy Market Trends and Growth Opportunities
- 10.2.1 Middle East and Africa Liquid Biopsy Market Outlook by Type
- 10.2.2 Middle East and Africa Liquid Biopsy Market Outlook by Application
- 10.3 Middle East and Africa Liquid Biopsy Market Outlook by Country
- 10.3.1 Saudi Arabia Liquid Biopsy Market Outlook, 2021- 2032
- 10.3.2 The UAE Liquid Biopsy Market Outlook, 2021- 2032
- 10.3.3 Rest of Middle East Liquid Biopsy Market Outlook, 2021- 2032
- 10.3.4 South Africa Liquid Biopsy Market Outlook, 2021- 2032
- 10.3.5 Egypt Liquid Biopsy Market Outlook, 2021- 2032
- 10.3.6 Rest of Africa Liquid Biopsy Market Outlook, 2021- 2032
- 11. Company Profiles
- 11.1 Leading 10 Companies
- Biocept Inc
- Bio-Rad Laboratories Inc
- Exact Sciences Corp
- F. Hoffmann-La Roche Ltd
- Guardant Health Inc
- Illumina Inc
- MDxHealth
- Myriad Genetics Inc
- QIAGEN N.V.
- Sysmex Inostics
- Thermo Fisher Scientific Inc
- 11.2 Overview
- 11.3 Products and Services
- 11.4 SWOT Profile
- 12. Appendix
- 12.1 Subscription Options
- 12.2 Customization Options
- 12.3 Publisher Details
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
